Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer

P4-02-06: Progesterone Receptor Expression Predicts Poor Outcome in Estrogen Receptor Positive, Lymph Node Negative Breast Cancer – A Population Based Study.

10.1158/0008-5472.sabcs11-p4-02-06 ◽

2011 ◽

Author(s):

CA Purdie ◽

P Quinlan ◽

LB Jordan ◽

A Ashfield ◽

L Baker ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Population Based ◽

Positive Lymph Node ◽

Receptor Expression ◽

Progesterone Receptor Expression ◽

Population Based Study ◽

Node Negative ◽

Node Negative Breast Cancer ◽

Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study

World Journal of Surgical Oncology ◽

10.1186/s12957-018-1539-7 ◽

2018 ◽

Vol 16 (1) ◽

Cited By ~ 1

Author(s):

Jin-Li Wei ◽

Jia-Xin Zhang ◽

De-Yuan Fu

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Progesterone Receptor ◽

Male Breast Cancer ◽

Population Based ◽

Male Breast ◽

Population Based Study ◽

The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer

Breast Cancer ◽

10.1007/s12282-020-01130-y ◽

2020 ◽

Author(s):

Wakako Tajiri ◽

Hideki Ijichi ◽

Katsumi Takizawa ◽

Yumiko Koi ◽

Takanobu Masuda ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Distant Recurrence ◽

Clinical Usefulness ◽

HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women

Breast Cancer Research ◽

10.1186/s13058-018-1072-1 ◽

2018 ◽

Vol 20 (1) ◽

Cited By ~ 2

Author(s):

Anja Kathrin Wege ◽

Dominik Chittka ◽

Stefan Buchholz ◽

Monika Klinkhammer-Schalke ◽

Simone Diermeier-Daucher ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Estrogen Receptor ◽

Postmenopausal Women ◽

Tamoxifen Treatment ◽

Her4 Expression ◽

Positive Breast Cancer

Adjuvant tamoxifen for pre- and postmenopausal women with estrogen receptor positive, node positive breast cancer: A randomized study

Breast Cancer Research and Treatment ◽

10.1007/bf00690184 ◽

1995 ◽

Vol 36 (1) ◽

pp. 49-53 ◽

Cited By ~ 14

Author(s):

S. Gundersen ◽

E. Hannisdal ◽

J. A. S�reide ◽

A. Skarstein ◽

J. E. Varhaug

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Postmenopausal Women ◽

Randomized Study ◽

Positive Node ◽

Adjuvant Tamoxifen ◽

Node Positive ◽

Positive Breast Cancer

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250mg With Fulvestrant 500mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer

Breast Diseases A Year Book Quarterly ◽

10.1016/j.breastdis.2012.04.003 ◽

2012 ◽

Vol 23 (2) ◽

pp. 190-191

Author(s):

V.C. Jordan

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Advanced Breast ◽

Phase Iii ◽

Phase Iii Trial ◽

Aromatase inhibitors versus tamoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies.

10.1158/0008-5472.sabcs-12 ◽

2009 ◽

Cited By ~ 17

Author(s):

JN Ingle ◽

M Dowsett ◽

J Cuzick ◽

C Davies

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Adjuvant Therapy ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Randomized Trials ◽

Meta Analyses ◽

Switching Strategies ◽

Positive Breast Cancer

A Phase II Study (FINDER 2) Comparing Three Dosing Regimens of Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Advanced Breast Cancer.

10.1158/0008-5472.sabcs-09-4095 ◽

2009 ◽

Author(s):

K. Pritchard ◽

J. Rolski ◽

Z. Pápai ◽

L. Mauriac ◽

F. Cardoso ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Dosing Regimens

Abstract P5-06-20: Usefulness of CTS5 for the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer

10.1158/1538-7445.sabcs19-p5-06-20 ◽

2020 ◽

Author(s):

Wakako Tajiri ◽

Azusa Sugii ◽

Hideki Ijichi ◽

Hiroki Ueo ◽

Chinami Koga ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Distant Recurrence ◽

Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China

Clinical Drug Investigation ◽

10.1007/s40261-019-00842-0 ◽

2019 ◽

Vol 40 (1) ◽

pp. 25-32 ◽

Cited By ~ 2

Author(s):

Xiaoxia Wei ◽

Hong Sun ◽

Jie Zhuang ◽

Xiuhua Weng ◽

Bin Zheng ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cost Effectiveness ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Early Breast Cancer ◽

Cost Effectiveness Analysis ◽

Pharmacogenetic Testing ◽

Effectiveness Analysis ◽